Aldrich ChemFiles 2007, 7.8, 5.

Aldrich ChemFiles 2007, 7.8, 5.

2,4-Dibromothiazole has been gaining increasing popularity as a building block in the synthesis of several interesting targets. Bach and co-workers have reported the regioselective metalation of this building block in a route to furnish the eastern fragment of the thiazole peptide GE2270 A (Scheme 1).1

Scheme 1(677914)

A formal enantioselective approach to (–)-mycothiazole was described which began with the chemoselective substitution of the bromine at the 2-position in 2,4-dibromothiazole (Scheme 2).2 The racemic product was achieved with an overall yield of 5% over 18 steps. Similarly, Panek reported regioselective Negishi cross-coupling at the 2-position in his total synthesis of cystothiazoles A and B (Scheme 3).3

Scheme 2(677914)

Scheme 3(677914)

Several groups have reported the use of 2-amino-4,5,6,7- tetrahydrobenzothiazole in the synthesis of various inhibitors.4 Most recently, Kraus, Maina, and co-workers have developed several pifithrin-a analogues from 2-amino-4,5,6,7- tetrahydrobenzothiazole (Scheme 4).4a These analogues are potent p53 inhibitors, and could prove effective in therapies for various neurodegenerative disorders.

Scheme 4(685372)

back to top




  1. Delgado, O. et al. J. Org. Chem. 2006, 71, 4599.
  2. Le Flohic, A. et al. Org. Lett. 2005, 7, 339.
  3. Shao, J.; Panek, J. S. Org. Lett. 2004, 6, 3083.
  4. (a) Pietrancosta, N. et al. J. Med. Chem. 2006, 49, 3645. (b) Barchéchath, S. D. et al. J. Med. Chem. 2005, 48, 6409. (c) Costanzo, M. J. et al. J. Med. Chem. 2005, 48, 1984.

back to top

Related Links